Pharmaceutical formulation containing gelling agent
C Wright, B Oshlack, C Breder - US Patent App. 10/214,412, 2003 - Google Patents
Disclosed in certain embodiments is a controlled release oral dosage form comprising a
therapeutically effective amount of a drug susceptible to abuse together with one or more …
therapeutically effective amount of a drug susceptible to abuse together with one or more …
Methods and compositions for deterring abuse of opioid containing dosage forms
V Kumar, D Dixon, D Tewari… - US Patent 7,201,920, 2007 - Google Patents
US7201920B2 - Methods and compositions for deterring abuse of opioid containing dosage
forms - Google Patents US7201920B2 - Methods and compositions for deterring abuse of opioid …
forms - Google Patents US7201920B2 - Methods and compositions for deterring abuse of opioid …
Pharmaceutical formulation containing gelling agent
C Wright, B Oshlack, C Breder - US Patent 8,337,888, 2012 - Google Patents
Disclosed in certain embodiments is a controlled release oral dosage form comprising a
therapeutically effective amount of a drug susceptible to abuse together with one or more …
therapeutically effective amount of a drug susceptible to abuse together with one or more …
Sustained release opioid formulations and method of use
G Boehm, A Liang - US Patent App. 10/667,570, 2005 - Google Patents
The invention combines two different Subunits with different release profiles in novel
Sustained-release oral dosage forms. In particular, the oral dosage forms include a Subunit …
Sustained-release oral dosage forms. In particular, the oral dosage forms include a Subunit …
Morphine controlled release system
G Fischer, D Bar-Shalom, L Slot, C Andersen - US Patent 8,877,241, 2014 - Google Patents
(73) Assignee: Egalet Ltd., London (GB)(*) Notice: Subject to any disclaimer, the term of this
patent is extended or adjusted under 35 USC 154 (b) by 2251 days.(21) Appl. No …
patent is extended or adjusted under 35 USC 154 (b) by 2251 days.(21) Appl. No …
Methods and compositions for deterring abuse of opioid containing dosage forms
V Kumar, D Dixon, D Tewari… - US Patent 7,510,726, 2009 - Google Patents
US7510726B2 - Methods and compositions for deterring abuse of opioid containing dosage
forms - Google Patents US7510726B2 - Methods and compositions for deterring abuse of opioid …
forms - Google Patents US7510726B2 - Methods and compositions for deterring abuse of opioid …
Encased tamper resistant controlled release dosage forms
HH Huang - US Patent 8,808,740, 2014 - Google Patents
In certain embodiments, the present invention is directed to a solid controlled release
dosage form comprising: a core comprising a first portion of an opioid analgesic dispersed in …
dosage form comprising: a core comprising a first portion of an opioid analgesic dispersed in …
Morphine polymer release system
G Fischer, D Bar-Shalom, L Slot… - US Patent App. 10 …, 2004 - Google Patents
(57) ABSTRACT A pharmaceutical composition for controlled release of an active
Substance. The active Substance is released into an aqueous medium by erosion of at least …
Substance. The active Substance is released into an aqueous medium by erosion of at least …
Methods and compositions for deterring abuse of opioid containing dosage forms
V Kumar, D Dixon, D Tewari… - US Patent 7,476,402, 2009 - Google Patents
US7476402B2 - Methods and compositions for deterring abuse of opioid containing dosage
forms - Google Patents US7476402B2 - Methods and compositions for deterring abuse of opioid …
forms - Google Patents US7476402B2 - Methods and compositions for deterring abuse of opioid …
Pharmaceutical composition containing gelling agent
C Wright, B Oshlack, C Breder - US Patent 8,389,007, 2013 - Google Patents
Disclosed in certain embodiments is a controlled release oral dosage form comprising a
therapeutically effective amount of a drug susceptible to abuse together with one or more …
therapeutically effective amount of a drug susceptible to abuse together with one or more …